Hair loss breakthrough? study tests top treatments for CCCA
NCT ID NCT04207931
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 250 African-American women with a type of scarring hair loss called CCCA. Researchers will compare how well different treatments—like steroid creams, steroid injections, an oral antibiotic, and minoxidil—work over 18 months. The goal is to see which approach best slows hair loss and encourages regrowth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Topical steroids (clobetasol, betamethasone, fluocinonide), triamcinolone acetonide injections, doxycycline, minoxidil
- What this could lead to
- If successful, this study could identify which combination of treatments works best to stop hair loss and promote regrowth in women with CCCA.
- What could go wrong
- This is an observational comparison of existing treatments, not a test of a new drug. Results may not apply to all patients, and some treatments have side effects like skin thinning or antibiotic resistance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA (CCCA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wake Forest Baptist Health Department of Dermatology
RECRUITINGWinston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.